₹357.20
+0.55
(+0.15%)
as on
as on September 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.46%
Downside
0.48%
Upside
52 Week's Low
52 Week's High
16.35%
Downside
41.17%
Upside
as on September 8, 2025 at 4:01 pm IST
Market Cap
₹3,576.40 Cr
Return on Equity (ROE)
19.57
PE Ratio (TTM)
57.8
Return on capital employed (ROCE)
16.52
Industry PE ratio
42.41
Beta (LTM)
0.9
P/B Ratio
5.33
Dividend Yield
0.04
PEG Ratio
-22.85
Quarterly Earnings Growth YOY
-37.34
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on September 8, 2025 at 4:01 pm IST
Gufic Bio in the last 5 years
Lowest (0.00x)
March 28, 2024
Industry (42.41x)
September 5, 2025
Today (57.80x)
September 5, 2025
Highest (65.57x)
July 30, 2025
Today’s Price to Earnings Ratio: 57.80x
Compare market cap, revenue, PE, and other key metrics of Gufic Bio with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 3,576.40 | 67.15% | 0.70 | 86 | 806 | |
NA | 69.88 | 3.03% | 0.00 | 1 | 33 | |
NA | 44.49 | -17.01% | 0.00 | -22 | 104 | |
NA | 120.66 | 59.56% | 0.00 | 14 | 95 | |
NA | 162.34 | 98.3% | 0.00 | 6 | 113 |
Search interest for Gufic BioSciences Ltd Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
Check out the Mutual Funds with significant holdings in Gufic Bio.
View detailed summary of the earnings and dividend history of Gufic Bio.
Gufic BioSciences Ltd’s net profit fell -37.34% since last year same period to ₹13.07Cr in the Q1 2025-2026. On a quarterly growth basis, Gufic BioSciences Ltd has generated 69.3% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Gufic BioSciences Ltd has declared dividend of ₹0.10 per share on 29 May 2024 - translating a dividend yield of 0.06%.
Read More about DividendsCheck stock indices that include Gufic Bio.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.31% to 0.32% in Jun 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 23.79% to 23.80% in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.51% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 16.2% return, outperforming this stock by 25.2%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.1% return, outperforming this stock by 81.5%
MF Holding Down
Mutual Funds have decreased holdings from 3.39% to 3.38% in Jun 2025 quarter
Price Dip
In the last 7 days, GUFICBIO stock has moved down by -1.8%
Organisation | Gufic BioSciences Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Jayesh P Choksi |
E-voting on shares | Click here to vote |
Gufic Bio share price today stands at ₹357.2 as on at the close of the market. Gufic Bio share today touched a day high of ₹358.9 and a low of ₹352.
Gufic Bio touched a 52 week high of ₹504.25 and a 52 week low of ₹298.8. Gufic Bio share price today i.e. is closed at ₹357.2, which is -29.16% down from its 52 week high and 19.54% up from its 52 week low.
Gufic Bio market capitalisation is ₹3,576.40 Cr as on .
To buy Gufic Bio shares, you need to follow these steps:
Gufic Bio trading volume is 23.90K as on . This means that 23.90K shares of Gufic Bio were bought and sold on the stock market during today's trading session.